Navigation Links
Organ Donors Solicited During UKs National Transplant Week

National Transplant Week this year, in UK, is being taken very seriously. The campaign, which was kicked off recently aims to make aware the desperate need of organs , required to save thousands of lives across the UK.

The campaign has been launched to raise organ donors too, not just for the 7,500 people currently on the transplant list, but also for the hundreds more who add their names every month.

In the UK every year, more than 600 patients have liver transplants with organs from dead donors. Currently, there are around 311 people on the liver transplant waiting list in the UK.

The number of donors is far exceeded by the number of patients desperately waiting for a transplant. According to specialists, around a fifth of these die while waiting. The average patient has to wait for up to a year for a suitable liver to become available.

For those lucky enough to get an organ, the miracle continues. Stephen Lomas, 51, the recipient of the first adult "live donor" liver transplant is making excellent progress. Consultants at St James's Hospital in Leeds carried out the pioneering operation during which Lomass son David, 20, donated 60 per cent of his healthy liver to his father. The surgeons believe the technique will offer new hope to the 300 or so people on the liver transplant waiting list at any one time.

Cystic fibrosis is another such disorder that can be helped by organ transplants. The first successful heart-lung transplant for cystic fibrosis was performed in 1985. Transplantation is not a magic cure for cystic fibrosis. Although patients have new lungs that won't develop CF, they have to continue taking medication for the rest of the body, which still has it. 74 per cent of lung transplant patients survive one year, and many go on to lead full lives.


'"/>




Page: 1

Related medicine news :

1. Exclusive breast-feeding advised for six months in infants recommends World Health Organization
2. Organs made from cloned embryos
3. New fertility drug development techniques by Organon
4. World Health Organisation Takes a Historic Decision and Approves Treaty to Discourage Smoking
5. World Health Organisation Takes a Historic Decision and Approves Treaty to Discourage Smoking
6. World Health Organisation Takes a Historic Decision and Approves Treaty to Discourage Smoking
7. Transfer Of Rabies Virus Possible From Organ Donor To Recipient
8. Government Organisation Proposes Strict Guidelines For SubStandard Medical Devices
9. Collaborations planned between British Organization and Indian health care industry
10. Stem cells Can Generate Organs In Labs
11. Kasturba Medical College Organizes CME- Orth 2005 From 4th To 6th November
Post Your Comments:
(Date:7/9/2008)... InsuranceSpecialists.com, ...otes for almost a decade, now offers comprehensive...n presidential candidates are taking on health ref...ertisement-free, supplies unbiased material on med...s to help consumers make the best choices in cover...
(Date:7/8/2008)...Cincinnati, OH, July 7, 2008Girls moving through a...ht gain, but the reasons for this are not always c...in are easily overlooked. A new study soon to be ...the effect of Internet usage, sleep, and alcohol a... girls. , Dr. Catherine Berkey and colleagues ...
(Date:7/8/2008)...ose who had phlebotomy were 37% less likely to dev...hDay News) -- Blood letting to reduce levels of ir...uce their chance of developing cancer, according t...ood have previously been linked with a lower cance...ults were based on a randomized controlled trial o...
(Date:7/8/2008)... Physicians Cite Patient Concerns about Delays in...NGTON, Va., July 8 /PRNewswire-USNewswire/ -- The ...le medical equipment has created,concern and chaos...,officials, and home medical equipment providers a...etropolitan areas on July 1., The bidding program...
Breaking Medicine News(10 mins):Health News:InsuranceSpecialists.com Looks at the Candidates and Health Reform 2Health News:InsuranceSpecialists.com Looks at the Candidates and Health Reform 3Health News:The Internet, alcohol and sleep 2Health News:Medicare Bidding Program Creates Major Problems for Physicians, Hospitals, and Beneficiaries Seeking Home Medical Equipment 2Health News:Medicare Bidding Program Creates Major Problems for Physicians, Hospitals, and Beneficiaries Seeking Home Medical Equipment 3Health News:Medicare Bidding Program Creates Major Problems for Physicians, Hospitals, and Beneficiaries Seeking Home Medical Equipment 4Health News:Medicare Bidding Program Creates Major Problems for Physicians, Hospitals, and Beneficiaries Seeking Home Medical Equipment 5
...ll be cycling across the Indian state of Rajasthan... of the women and children living in the state.// ... between 16 November and 26 November 2006. Jayne W...eportedly undergoing training to accomplish this t...
... developing chronic lung problems and asthma if th...ding to Alfred Bernard, the professor of toxicolog...e also added that the levels of the irritant trich...paddling pools than in adult pools, and that his r...
...onging to the Tulane University have come to the c...ure heart problems and the hardening of the arteri...ical markers of inflammation. //A test that is rel...y the researchers for testing of inflammations. ...
...de in diagnoses and treatment of the fatal childho...result in a cure rate of 90%, according to researc... Hospital.// The progressive improvement in the ...children with ALL survived, reflects in large part...
Other Medicine News:Health News:Children Face Risk While Swimming 2Health News:Acute Lymphoblastic Leukemia May Attain a 90% Cure Rate 2
(Date:7/7/2008)...Newswire-FirstCall/ -- Biopure Corporation,(Nasdaq...ons with the Food,and Drug Administration (FDA) on...a new clinical trial of Hemopure(R) [hemoglobin gl...roposed to study use of Hemopure,in patients suffe...use,transfusion with blood components. Currently, ...
(Date:7/6/2008)...keting Authorization Application currently ..., July 7 /- Cell Therapeuti...ed the publication of results from its,randomized ...oliglumex,CT-2103) with gemcitabine or vinorelbin... patients with previously untreated non-small cell...
(Date:7/3/2008)...BRIDGE Massachusetts, July 3,/PRNewswire-FirstCall...logy company, Jerini AG for an equity purchase pr... (HAE) product, FIRAZYR(R), to its Human Genetic ...global sales expected to be around $350-400 milli...e environment, - Expected to be accretive for Non...
(Date:7/1/2008)...Regimen sNDA Targeted for Fiscal Year-end ...J., July 1, 2008 /- Eisai Corporation...efficacy data from a trial,initiated in 2002 compa...re,(BSC) in elderly patients with myelodysplastic ...atistically significant advantage of Dacogen,treat...
Breaking Medicine Technology:Biopure Announces Meeting With FDA 2Biopure Announces Meeting With FDA 3Complete Study Results Comparing CTI's OPAXIO(TM) With Gemcitabine or Vinorelbine in Performance Status (PS 2) NSCLC Patients Published in Journal of Thoracic Oncology 2Complete Study Results Comparing CTI's OPAXIO(TM) With Gemcitabine or Vinorelbine in Performance Status (PS 2) NSCLC Patients Published in Journal of Thoracic Oncology 3Complete Study Results Comparing CTI's OPAXIO(TM) With Gemcitabine or Vinorelbine in Performance Status (PS 2) NSCLC Patients Published in Journal of Thoracic Oncology 4Complete Study Results Comparing CTI's OPAXIO(TM) With Gemcitabine or Vinorelbine in Performance Status (PS 2) NSCLC Patients Published in Journal of Thoracic Oncology 5Shire to add New Orphan Drug to its HGT Portfolio - EU Launch Imminent 2Shire to add New Orphan Drug to its HGT Portfolio - EU Launch Imminent 3Shire to add New Orphan Drug to its HGT Portfolio - EU Launch Imminent 4Shire to add New Orphan Drug to its HGT Portfolio - EU Launch Imminent 5Shire to add New Orphan Drug to its HGT Portfolio - EU Launch Imminent 6Shire to add New Orphan Drug to its HGT Portfolio - EU Launch Imminent 7Shire to add New Orphan Drug to its HGT Portfolio - EU Launch Imminent 8Eisai Provides Preliminary Efficacy Update On EORTC Phase III Trial of Dacogen(R) Versus Supportive Care in Patients With Myelodysplastic Syndromes 2Eisai Provides Preliminary Efficacy Update On EORTC Phase III Trial of Dacogen(R) Versus Supportive Care in Patients With Myelodysplastic Syndromes 3Eisai Provides Preliminary Efficacy Update On EORTC Phase III Trial of Dacogen(R) Versus Supportive Care in Patients With Myelodysplastic Syndromes 4Mutant gene causes epilepsy intellectual disability in women 19019 1Mutant gene causes epilepsy intellectual disability in women 19019 2Key step in the puncture mechanism of cell death revealed 19016 1Key step in the puncture mechanism of cell death revealed 19016 2PLC Medical Systems to Demonstrate RenalGuard 28TM 29 at EuroPCR 2008 19013 1PLC Medical Systems to Demonstrate RenalGuard 28TM 29 at EuroPCR 2008 19013 2PLC Medical Systems to Demonstrate RenalGuard 28TM 29 at EuroPCR 2008 19013 3PLC Medical Systems to Demonstrate RenalGuard 28TM 29 at EuroPCR 2008 19013 4Diet Industry Newcomer Hits the 1 Million Unit Mark 19010 1Diet Industry Newcomer Hits the 1 Million Unit Mark 19010 2
...sented at Society for Biomolecular Sciences Confer...wire-FirstCall/ --,Lexicon Genetics Incorporated a...g potential therapeutic targets related to its,col... Biomolecular,Sciences 13th Annual Conference &...coveries were made in a collaboration,between Lexi...
... RIDGE, N.J., April 19, 2007 /PRNewswire-FirstCall...-based,biopharmaceutical company focused on acquir...r compounds, announced data from its,preclinical s...vation for the treatment of solid and hematologic ...r at the April 2007,Annual Meeting of the American...
Other Medicine Technology:Lexicon-Genentech Collaboration Yields Potential Therapeutic,Targets 2Lexicon-Genentech Collaboration Yields Potential Therapeutic,Targets 3Lexicon-Genentech Collaboration Yields Potential Therapeutic,Targets 4Lexicon-Genentech Collaboration Yields Potential Therapeutic,Targets 5VioQuest Pharmaceuticals Announces Data Presentation for Its Akt,Inhibitor VQD-002, at American Association for Cancer Research,Annual Meeting 2VioQuest Pharmaceuticals Announces Data Presentation for Its Akt,Inhibitor VQD-002, at American Association for Cancer Research,Annual Meeting 3VioQuest Pharmaceuticals Announces Data Presentation for Its Akt,Inhibitor VQD-002, at American Association for Cancer Research,Annual Meeting 4VioQuest Pharmaceuticals Announces Data Presentation for Its Akt,Inhibitor VQD-002, at American Association for Cancer Research,Annual Meeting 5
Facilitates retrieval of polypropylene guide thread from the nasal cavity when using Ritleng Bicanalicular systems and self threading Monoka systems.
...ead-guide reducing time and trauma in lacrimal duc... into the nasolacrimal duct and a thin prolene thr...hdrawn leaving the polypropylene thread to pull th... or Imperforate Nasolacrimal Duct. Silicone, Blue ...
...ead-guide reducing time and trauma in lacrimal duc... into the nasolacrimal duct and a thin prolene thr...hdrawn leaving the polypropylene thread to pull th... or Imperforate Nasolacrimal Duct. Silicone, Blue ...
For canalicular laceration or imperforate nasolacrimal duct. Medical grade silicone and Stainless Steel Probe. Box of 3, sterile. Note: Tubing securely swaged into malleable stainless steel probes. S
Medicine Products: